Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9,038.00 JPY | -3.07% |
|
-1.31% | +13.39% |
May. 30 | GMO Financial Gate to Transfer Listing to TSE Prime Market | MT |
May. 29 | GMO Financial Gate Gets Nod to Transfer Tokyo Bourse Listing to Prime Market | MT |
Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.96 | 4.08 | 4.17 | 4.5 | 4.95 | |||||
Return on Total Capital | 10.05 | 10.29 | 9.07 | 9.24 | 10.41 | |||||
Return On Equity % | 25.81 | 19.68 | 33.13 | 15.02 | 19.17 | |||||
Return on Common Equity | 26.8 | 20.14 | 33.79 | 15.02 | 19.17 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 72.16 | 67.43 | 66.87 | 63.35 | 65.19 | |||||
SG&A Margin | 32.13 | 29.27 | 28.35 | 24.95 | 26.89 | |||||
EBITDA Margin % | 36.46 | 36.51 | 36.67 | 36.12 | 38.72 | |||||
EBITA Margin % | 31.86 | 31.96 | 32.4 | 32.29 | 34.18 | |||||
EBIT Margin % | 31.86 | 31.96 | 32.4 | 32.29 | 34.18 | |||||
Income From Continuing Operations Margin % | 23.82 | 21.56 | 48.43 | 21.9 | 26.07 | |||||
Net Income Margin % | 23.07 | 21.16 | 48.02 | 21.35 | 25.35 | |||||
Net Avail. For Common Margin % | 23.61 | 21.16 | 48.02 | 21.35 | 25.35 | |||||
Normalized Net Income Margin | 20.27 | 19.37 | 21.27 | 19.93 | 21.38 | |||||
Levered Free Cash Flow Margin | 145.53 | -14.45 | -16.53 | 26.51 | 63.8 | |||||
Unlevered Free Cash Flow Margin | 145.86 | -14.23 | -16.31 | 26.74 | 64.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.2 | 0.2 | 0.21 | 0.22 | 0.23 | |||||
Fixed Assets Turnover | 15.62 | 10.88 | 13.43 | 18.31 | 20.29 | |||||
Receivables Turnover (Average Receivables) | 2.7 | 3.95 | 4.14 | 3.84 | 3.68 | |||||
Inventory Turnover (Average Inventory) | 11.17 | 8.74 | 10.43 | 11.75 | 9.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.24 | 1.43 | 1.65 | 1.58 | 1.46 | |||||
Quick Ratio | 0.99 | 1.07 | 1.18 | 1.17 | 1.14 | |||||
Operating Cash Flow to Current Liabilities | 0.36 | -0.05 | 0.05 | 0.04 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 135.37 | 92.37 | 88.07 | 95.17 | 99.36 | |||||
Days Outstanding Inventory (Average Inventory) | 32.76 | 41.75 | 35 | 31.06 | 39.81 | |||||
Average Days Payable Outstanding | 157.6 | 126.04 | 119.51 | 92.36 | 100.8 | |||||
Cash Conversion Cycle (Average Days) | 10.54 | 8.08 | 3.56 | 33.87 | 38.37 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 106.85 | 60.1 | 47.81 | 51.8 | 50.18 | |||||
Total Debt / Total Capital | 51.66 | 37.54 | 32.35 | 34.13 | 33.42 | |||||
LT Debt/Equity | 50.65 | 33.92 | 28.77 | 30.29 | 27.18 | |||||
Long-Term Debt / Total Capital | 24.49 | 21.19 | 19.46 | 19.95 | 18.1 | |||||
Total Liabilities / Total Assets | 82.58 | 73.16 | 67.35 | 67.57 | 69.3 | |||||
EBIT / Interest Expense | 60.86 | 88.18 | 90.53 | 87.48 | 87.57 | |||||
EBITDA / Interest Expense | 69.65 | 100.74 | 102.47 | 97.84 | 99.19 | |||||
(EBITDA - Capex) / Interest Expense | 67.17 | 99.11 | 100.68 | 95.57 | 97.47 | |||||
Total Debt / EBITDA | 2.97 | 2.28 | 2.31 | 2.15 | 1.86 | |||||
Net Debt / EBITDA | -5.4 | -4.72 | -4.76 | -3.94 | -4.23 | |||||
Total Debt / (EBITDA - Capex) | 3.08 | 2.32 | 2.35 | 2.21 | 1.89 | |||||
Net Debt / (EBITDA - Capex) | -5.6 | -4.8 | -4.84 | -4.03 | -4.31 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 2.88 | 26.09 | 20.71 | 25.49 | 16.9 | |||||
Gross Profit, 1 Yr. Growth % | 16.3 | 17.83 | 19.71 | 18.88 | 20.3 | |||||
EBITDA, 1 Yr. Growth % | 14.11 | 26.24 | 21.25 | 23.6 | 25.31 | |||||
EBITA, 1 Yr. Growth % | 11.47 | 26.46 | 22.39 | 25.09 | 23.72 | |||||
EBIT, 1 Yr. Growth % | 11.47 | 26.46 | 22.39 | 25.09 | 23.72 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 55.82 | 14.1 | 171.21 | -43.26 | 39.15 | |||||
Net Income, 1 Yr. Growth % | 44.75 | 15.66 | 173.89 | -44.21 | 38.81 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.16 | 20.46 | 32.59 | 17.59 | 25.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 47.37 | 12.46 | 170.87 | -44.11 | 38.66 | |||||
Accounts Receivable, 1 Yr. Growth % | -21.09 | -4.4 | 35.47 | 35.73 | 11.38 | |||||
Inventory, 1 Yr. Growth % | 595.65 | 15.56 | -7.93 | 56.98 | 32.31 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 618.38 | 6.3 | -10.28 | -5.34 | 16.91 | |||||
Total Assets, 1 Yr. Growth % | 37.17 | 12.2 | 26.9 | 6.93 | 17.91 | |||||
Tangible Book Value, 1 Yr. Growth % | 21.44 | 87.22 | 59.33 | 3.47 | 10.73 | |||||
Common Equity, 1 Yr. Growth % | 19.78 | 75.98 | 56.01 | 5.91 | 11.51 | |||||
Cash From Operations, 1 Yr. Growth % | 3.65K | -112.9 | -220.7 | -19.96 | 707.31 | |||||
Capital Expenditures, 1 Yr. Growth % | 174.36 | -42.76 | 31.02 | 64.8 | -6.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 24.87K | -112.52 | 38.06 | -301.28 | 181.29 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 18.04K | -112.3 | 38.36 | -305.82 | 179.93 | |||||
Dividend Per Share, 1 Yr. Growth % | 44.44 | 13.46 | 33.9 | 12.66 | 30.34 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.85 | 13.89 | 23.37 | 23.08 | 21.12 | |||||
Gross Profit, 2 Yr. CAGR % | 17.28 | 17.06 | 18.76 | 19.29 | 19.59 | |||||
EBITDA, 2 Yr. CAGR % | 23.13 | 20.02 | 23.72 | 22.42 | 24.45 | |||||
EBITA, 2 Yr. CAGR % | 22.79 | 18.73 | 24.41 | 23.73 | 24.4 | |||||
EBIT, 2 Yr. CAGR % | 22.79 | 18.73 | 24.41 | 23.73 | 24.4 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 36.14 | 33.34 | 75.91 | 24.05 | -11.14 | |||||
Net Income, 2 Yr. CAGR % | 33.86 | 29.39 | 77.99 | 23.62 | -12 | |||||
Normalized Net Income, 2 Yr. CAGR % | 26.16 | 17.27 | 26.38 | 24.86 | 21.43 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 34.08 | 28.74 | 74.54 | 23.04 | -11.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | -9.74 | -13.14 | 13.8 | 35.6 | 22.95 | |||||
Inventory, 2 Yr. CAGR % | 374.34 | 183.53 | 3.14 | 20.22 | 44.12 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 187.29 | 176.34 | -2.34 | -7.84 | 5.2 | |||||
Total Assets, 2 Yr. CAGR % | 28.19 | 24.06 | 19.32 | 16.49 | 12.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | 16.33 | 50.78 | 72.71 | 28.4 | 7.04 | |||||
Common Equity, 2 Yr. CAGR % | 13.13 | 45.19 | 65.69 | 28.54 | 8.68 | |||||
Cash From Operations, 2 Yr. CAGR % | 223.47 | 119.96 | -60.55 | -1.71 | 154.2 | |||||
Capital Expenditures, 2 Yr. CAGR % | 135.76 | 25.32 | -13.4 | 46.94 | 24.18 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 291.18 | 459.15 | -58.42 | 66.7 | 137.95 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 289.42 | 372.3 | -58.75 | 68.75 | 140.03 | |||||
Dividend Per Share, 2 Yr. CAGR % | 33.91 | 28.02 | 23.26 | 22.82 | 21.18 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.88 | 16.4 | 16.12 | 24.07 | 20.98 | |||||
Gross Profit, 3 Yr. CAGR % | 16.44 | 17.46 | 17.94 | 18.8 | 19.63 | |||||
EBITDA, 3 Yr. CAGR % | 26.74 | 24.16 | 20.43 | 23.68 | 23.38 | |||||
EBITA, 3 Yr. CAGR % | 26.74 | 24 | 19.93 | 24.63 | 23.73 | |||||
EBIT, 3 Yr. CAGR % | 28.05 | 24 | 19.93 | 24.63 | 23.73 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 38.21 | 28.36 | 68.94 | 20.64 | 28.89 | |||||
Net Income, 3 Yr. CAGR % | 37.26 | 27.49 | 66.14 | 20.91 | 28.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | 31.77 | 24.23 | 22.17 | 23.38 | 25.04 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 37.56 | 26.45 | 64.96 | 19.41 | 28.04 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.58 | -8 | 0.73 | 20.69 | 26.99 | |||||
Inventory, 3 Yr. CAGR % | 148.36 | 196.25 | 94.88 | 18.65 | 24.12 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 110.36 | 106.25 | 89.93 | -3.35 | -0.24 | |||||
Total Assets, 3 Yr. CAGR % | 32.19 | 22.62 | 25 | 15.04 | 16.96 | |||||
Tangible Book Value, 3 Yr. CAGR % | 18.66 | 36.33 | 53.58 | 45.6 | 22.21 | |||||
Common Equity, 3 Yr. CAGR % | 15.51 | 31.08 | 48.71 | 42.73 | 22.59 | |||||
Cash From Operations, 3 Yr. CAGR % | 204.1 | 10.5 | 80.08 | -50.06 | 98.31 | |||||
Capital Expenditures, 3 Yr. CAGR % | 62.91 | 47.08 | 27.19 | 7.32 | 26.42 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 272.66 | 24.21 | 250.79 | -29.66 | 98.46 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 270.54 | 23.09 | 213.68 | -29.51 | 99.76 | |||||
Dividend Per Share, 3 Yr. CAGR % | 37.51 | 26.71 | 29.95 | 19.62 | 25.28 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 29.62 | 28.03 | 18.21 | 19.03 | 18.1 | |||||
Gross Profit, 5 Yr. CAGR % | 27.38 | 24.63 | 17.36 | 18.19 | 18.6 | |||||
EBITDA, 5 Yr. CAGR % | 29.78 | 29.42 | 25.53 | 23.46 | 22.02 | |||||
EBITA, 5 Yr. CAGR % | 28.7 | 28.36 | 25.8 | 23.89 | 21.7 | |||||
EBIT, 5 Yr. CAGR % | 28.74 | 28.37 | 26.58 | 23.89 | 21.7 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 33.58 | 25.28 | 52.21 | 26.62 | 30.65 | |||||
Net Income, 5 Yr. CAGR % | 32.7 | 24.82 | 52.29 | 25.93 | 28.85 | |||||
Normalized Net Income, 5 Yr. CAGR % | 28.97 | 27.85 | 29.59 | 24.48 | 21.87 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 31.48 | 24.29 | 51.31 | 25.07 | 28.32 | |||||
Accounts Receivable, 5 Yr. CAGR % | 20.61 | -1.09 | 6.3 | 7.44 | 9.09 | |||||
Inventory, 5 Yr. CAGR % | 328.23 | 111.84 | 74.75 | 106.53 | 72.72 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 76.8 | 62.17 | 54.76 | 49.43 | 49.95 | |||||
Total Assets, 5 Yr. CAGR % | 35.63 | 31.51 | 26.89 | 20.13 | 19.75 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12 | 28.32 | 37.89 | 33.1 | 32.93 | |||||
Common Equity, 5 Yr. CAGR % | 14.41 | 25.19 | 33.44 | 30.06 | 31.18 | |||||
Cash From Operations, 5 Yr. CAGR % | 67.7 | 53.35 | 34.35 | 5.44 | 106.71 | |||||
Capital Expenditures, 5 Yr. CAGR % | 61.46 | 53.23 | 26.52 | 47.03 | 25.98 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 70.55 | 189.97 | 55 | 39.72 | 200.34 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 70.62 | 184.38 | 53.99 | 39.65 | 181.84 | |||||
Dividend Per Share, 5 Yr. CAGR % | 42.02 | 34.31 | 31.62 | 25.14 | 26.37 |
- Stock Market
- Equities
- 3769 Stock
- Financials GMO Payment Gateway, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions